[144] BRIXMOR PROPERTY GROUP INC. SEC Filing
Form 144 notice reports a proposed sale of 2,000 shares of Common stock with an aggregate market value of $51,480 and approximately 306,099,542 shares outstanding. The approximate date of sale is 07/17/2025 on the NYSE and the listed broker is THE CHARLES SCHWAB CORPORATION at 3000 Schwab Way Westlake TX 76262.
The filing discloses acquisition details for the securities to be sold: grants received as compensation on 04/27/2022 (4,671 shares), 04/26/2023 (5,885 shares), and 04/25/2024 (5,512 shares). The filer reports no securities sold in the past three months and includes the required representation regarding material nonpublic information and trading-plan disclosure language.
La comunicazione Form 144 segnala la proposta vendita di 2.000 azioni Common stock per un valore di mercato complessivo di $51.480 e con circa 306.099.542 azioni in circolazione. La data approssimativa della vendita 猫 il 17/07/2025 alla NYSE e il broker indicato 猫 THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
La dichiarazione riporta le modalit脿 di acquisizione dei titoli da vendere: assegni ricevuti come compenso il 27/04/2022 (4.671 azioni), il 26/04/2023 (5.885 azioni) e il 25/04/2024 (5.512 azioni). Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la dichiarazione richiesta relativa a informazioni privilegiate materiali e al linguaggio sul piano di negoziazione.
El aviso Form 144 informa de la propuesta de venta de 2.000 acciones de Common stock con un valor de mercado agregado de $51,480 y aproximadamente 306.099.542 acciones en circulaci贸n. La fecha aproximada de la venta es el 17/07/2025 en la NYSE y el corredor indicado es THE CHARLES SCHWAB CORPORATION en 3000 Schwab Way, Westlake TX 76262.
La presentaci贸n divulga los detalles de adquisici贸n de los valores a vender: adjudicaciones recibidas como compensaci贸n el 27/04/2022 (4.671 acciones), el 26/04/2023 (5.885 acciones) y el 25/04/2024 (5.512 acciones). El declarante informa que no vendi贸 valores en los 煤ltimos tres meses e incluye la representaci贸n requerida sobre informaci贸n material no p煤blica y el lenguaje relativo al plan de negociaci贸n.
Form 144 韱奠電� 氤错喌欤� 2,000欤� 毵り皝 鞝滌晥鞚� 氤搓碃頃╇媹雼� 齑� 鞁滉皜 齑濎暋鞚� $51,480鞚措┌ 鞙犿喌 欤检嫕 靾橂姅 鞎� 306,099,542欤检瀰雼堧嫟. 鞓堨儊 毵り皝鞚检潃 2025雲� 7鞗� 17鞚� NYSE鞚措┌, 旮办灛霅� 欷戧皽鞚胳潃 THE CHARLES SCHWAB CORPORATION(欤检唽: 3000 Schwab Way, Westlake TX 76262)鞛呺媹雼�.
靹滊電� 毵り皝 鞓堨爼 歃濌秾鞚� 旆摑 雮挫棴鞚� 瓿店皽頃╇媹雼�: 氤挫垬搿� 靾橂牴霅� 攵�鞐秳 鈥� 2022雲� 4鞗� 27鞚�(4,671欤�), 2023雲� 4鞗� 26鞚�(5,885欤�), 2024雲� 4鞗� 25鞚�(5,512欤�). 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈 雮挫棎 歃濌秾鞚� 毵る弰頃橃 鞎婌晿鞚岇潉 氤搓碃頄堨溂氅�, 欷戩殧 牍勱车臧� 鞝曤炒 甏�霠� 歆勳垹瓿� 瓯半灅 瓿勴殟 甏�霠� 氍戈惮毳� 韽暔頃橁碃 鞛堨姷雼堧嫟.
L'avis Form 144 signale une proposition de vente de 2 000 actions de Common stock pour une valeur marchande totale de 51 480 $ et environ 306 099 542 actions en circulation. La date approximative de la vente est le 17/07/2025 脿 la NYSE et le courtier indiqu茅 est THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
Le d茅p么t r茅v猫le les d茅tails d'acquisition des titres 脿 vendre : attributions re莽ues en r茅mun茅ration le 27/04/2022 (4 671 actions), le 26/04/2023 (5 885 actions) et le 25/04/2024 (5 512 actions). Le d茅clarant indique n'avoir vendu aucun titre au cours des trois derniers mois et inclut la d茅claration requise concernant les informations mat茅rielles non publiques ainsi que le libell茅 relatif au plan de n茅gociation.
Die Form-144-Mitteilung meldet einen geplanten Verkauf von 2.000 Aktien der Common stock mit einem Gesamtkurswert von $51.480 und etwa 306.099.542 ausstehenden Aktien. Das ungef盲hre Verkaufsdatum ist der 17.07.2025 an der NYSE, der angegebene Broker ist THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
Die Einreichung legt die Erwerbsdetails der zu ver盲u脽ernden Wertpapiere offen: Zuteilungen als Verg眉tung erhalten am 27.04.2022 (4.671 Aktien), 26.04.2023 (5.885 Aktien) und 25.04.2024 (5.512 Aktien). Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enth盲lt die erforderliche Zusicherung zu wesentlichen nicht枚ffentlichen Informationen sowie die Formulierung zum Handelsplan.
- Sale specifics disclosed: number of shares (2,000), aggregate value ($51,480), approximate sale date (07/17/2025), and exchange (NYSE)
- Acquisition history provided: grants dated 04/27/2022 (4,671), 04/26/2023 (5,885), and 04/25/2024 (5,512) listed as compensation
- No recent dispositions: filer reports nothing sold in the past three months, indicating this is not part of an ongoing rapid sell-down
- Required attestation present: representation regarding material nonpublic information and Rule 10b5-1/trading-plan language included
- Missing filer identifiers in provided excerpt: filer CIK/CCC and submission contact fields appear blank in the content shown
- Issuer header fields incomplete: issuer name, SEC file number, address and phone are not populated in the provided tables
- Potential procedural concern if originals lack identifiers: absence of clear filer and issuer identification in the excerpt could hinder traceability
Insights
TL;DR: Routine insider sale notice for 2,000 shares, limited financial impact given size versus ~306M outstanding shares.
The Form 144 documents a proposed sale of 2,000 common shares valued at $51,480 against an issuer base of 306,099,542 shares outstanding, implying an immaterial dilution or market impact from this specific sale. Acquisition history shows the shares arose from compensation grants over three consecutive years, confirming this is an insider disposition of previously awarded equity rather than a primary issuance. The filing also reports no sales in the prior three months, which supports the characterization of this as an isolated disposition. Overall, the disclosure is consistent with routine Section 144 compliance and does not present material financial information for investors.
TL;DR: Compliance-focused filing that meets basic Rule 144 disclosure but omits some issuer/filer identifying fields in the presented excerpt.
The document includes the mandatory representations regarding lack of material nonpublic information and the signature/attestation language, fulfilling key governance and legal attestations for a Rule 144 sale. Acquisition entries identify compensation grants and dates, which aids traceability of insider holdings. However, the provided content excerpt lacks explicit filer CIK/CCC and full issuer header details in the issuer section as presented here; if truly missing from the filed form, that would be a procedural deficiency. As presented, the filing otherwise documents the sale particulars required for market transparency.
La comunicazione Form 144 segnala la proposta vendita di 2.000 azioni Common stock per un valore di mercato complessivo di $51.480 e con circa 306.099.542 azioni in circolazione. La data approssimativa della vendita 猫 il 17/07/2025 alla NYSE e il broker indicato 猫 THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
La dichiarazione riporta le modalit脿 di acquisizione dei titoli da vendere: assegni ricevuti come compenso il 27/04/2022 (4.671 azioni), il 26/04/2023 (5.885 azioni) e il 25/04/2024 (5.512 azioni). Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e include la dichiarazione richiesta relativa a informazioni privilegiate materiali e al linguaggio sul piano di negoziazione.
El aviso Form 144 informa de la propuesta de venta de 2.000 acciones de Common stock con un valor de mercado agregado de $51,480 y aproximadamente 306.099.542 acciones en circulaci贸n. La fecha aproximada de la venta es el 17/07/2025 en la NYSE y el corredor indicado es THE CHARLES SCHWAB CORPORATION en 3000 Schwab Way, Westlake TX 76262.
La presentaci贸n divulga los detalles de adquisici贸n de los valores a vender: adjudicaciones recibidas como compensaci贸n el 27/04/2022 (4.671 acciones), el 26/04/2023 (5.885 acciones) y el 25/04/2024 (5.512 acciones). El declarante informa que no vendi贸 valores en los 煤ltimos tres meses e incluye la representaci贸n requerida sobre informaci贸n material no p煤blica y el lenguaje relativo al plan de negociaci贸n.
Form 144 韱奠電� 氤错喌欤� 2,000欤� 毵り皝 鞝滌晥鞚� 氤搓碃頃╇媹雼� 齑� 鞁滉皜 齑濎暋鞚� $51,480鞚措┌ 鞙犿喌 欤检嫕 靾橂姅 鞎� 306,099,542欤检瀰雼堧嫟. 鞓堨儊 毵り皝鞚检潃 2025雲� 7鞗� 17鞚� NYSE鞚措┌, 旮办灛霅� 欷戧皽鞚胳潃 THE CHARLES SCHWAB CORPORATION(欤检唽: 3000 Schwab Way, Westlake TX 76262)鞛呺媹雼�.
靹滊電� 毵り皝 鞓堨爼 歃濌秾鞚� 旆摑 雮挫棴鞚� 瓿店皽頃╇媹雼�: 氤挫垬搿� 靾橂牴霅� 攵�鞐秳 鈥� 2022雲� 4鞗� 27鞚�(4,671欤�), 2023雲� 4鞗� 26鞚�(5,885欤�), 2024雲� 4鞗� 25鞚�(5,512欤�). 鞝滌稖鞚胳潃 斓滉芳 3臧滌洈 雮挫棎 歃濌秾鞚� 毵る弰頃橃 鞎婌晿鞚岇潉 氤搓碃頄堨溂氅�, 欷戩殧 牍勱车臧� 鞝曤炒 甏�霠� 歆勳垹瓿� 瓯半灅 瓿勴殟 甏�霠� 氍戈惮毳� 韽暔頃橁碃 鞛堨姷雼堧嫟.
L'avis Form 144 signale une proposition de vente de 2 000 actions de Common stock pour une valeur marchande totale de 51 480 $ et environ 306 099 542 actions en circulation. La date approximative de la vente est le 17/07/2025 脿 la NYSE et le courtier indiqu茅 est THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
Le d茅p么t r茅v猫le les d茅tails d'acquisition des titres 脿 vendre : attributions re莽ues en r茅mun茅ration le 27/04/2022 (4 671 actions), le 26/04/2023 (5 885 actions) et le 25/04/2024 (5 512 actions). Le d茅clarant indique n'avoir vendu aucun titre au cours des trois derniers mois et inclut la d茅claration requise concernant les informations mat茅rielles non publiques ainsi que le libell茅 relatif au plan de n茅gociation.
Die Form-144-Mitteilung meldet einen geplanten Verkauf von 2.000 Aktien der Common stock mit einem Gesamtkurswert von $51.480 und etwa 306.099.542 ausstehenden Aktien. Das ungef盲hre Verkaufsdatum ist der 17.07.2025 an der NYSE, der angegebene Broker ist THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.
Die Einreichung legt die Erwerbsdetails der zu ver盲u脽ernden Wertpapiere offen: Zuteilungen als Verg眉tung erhalten am 27.04.2022 (4.671 Aktien), 26.04.2023 (5.885 Aktien) und 25.04.2024 (5.512 Aktien). Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben, und enth盲lt die erforderliche Zusicherung zu wesentlichen nicht枚ffentlichen Informationen sowie die Formulierung zum Handelsplan.
FAQ
What does BRX's Form 144 report?
How many shares does BRX have outstanding according to the filing?
Were the shares to be sold acquired through purchase or compensation?
Has the filer sold other BRX securities in the past three months?
Who is the broker named in the Form 144?
